An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)

Overview of attention for article published in Pharmacogenetics and Genomics, August 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 10,566 followers.

Current Issue: An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance) https://t.co/kELRoLcmVR

01 Jul 2019

Reply Repost Favourite

Genetic analysis of #pancreaticcancer patients receiving gemcitabine-based chemotherapy finds that the rs2072671 variant may have a protective effect against neutropenia, or low white blood cell count. Drs. Kindler and Ratain collaborate: https://t.co/rDyb

10 May 2019

Reply Repost Favourite